PD
RGLS

Point72 (DIFC)’s Regulus Therapeutics RGLS Stock Holding History

Point72 (DIFC)’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,608
Closed -$2.81K – 2008
2025
Q1 		$2.81K Buy
+1,608
New +$2.12K ﹤0.01% 1551

Other funds holding RGLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Point72 (DIFC)'s RGLS Position: Q2 2025 in Review

Point72 (DIFC) sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 1,608 shares — an estimated $2.81K sold.

Point72 (DIFC) first reported a position in RGLS in Q1 2025 and held it in 1 quarter. The position peaked at $2.81K in Q1 2025. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

  • Point72 (DIFC) reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 1,608 Regulus Therapeutics shares in Q2 2025, an estimated $2.81K.
  • Point72 (DIFC) first reported a position in Regulus Therapeutics in Q1 2025 and held it in 1 quarter.
  • Point72 (DIFC)'s Regulus Therapeutics position peaked at $2.81K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.